nacmedi
prevent
copd
exacerb
restor
normal
antivir
innat
immun
respons
suppress
cigarett
smoke
perhap
copd
cigarett
smoke
major
caus
copd
predispos
patient
sever
respiratori
tract
infect
respiratori
viral
infect
rhinovirus
infl
uenza
virus
respiratori
syncyti
viru
main
caus
copd
exacerb
associ
diseas
progress
loss
lung
function
specifi
calli
sever
studi
confi
rmed
relationship
cigarett
smoke
risk
infl
uenza
infect
infl
uenza
infect
sever
cough
acut
chronic
phlegm
product
breathless
wheez
smoker
mechan
increas
suscept
infect
smoker
like
multifactori
clearli
includ
alter
immunolog
host
defens
demonstr
cigarett
smoke
extract
cse
suppress
host
antivir
activ
human
lung
model
thu
cigarett
smoke
exacerb
suscept
host
respiratori
infecti
diseas
attend
patholog
found
cse
treatment
inhibit
infl
uenzainduc
antivir
cytokin
express
human
model
associ
cseinhibit
messeng
rna
protein
express
major
rna
viru
sentinel
rigi
import
antivir
host
respons
howev
inhibit
viralmedi
rigi
induct
cse
prevent
antivir
cytokin
respons
restor
nac
interact
host
immun
respons
infl
uenza
viru
usual
determin
outcom
infect
restor
respons
nac
may
major
mechan
decreas
exacerb
demonstr
tse
et
al
patient
copd
editor
would
like
thank
dr
wu
colleagu
respons
articl
rais
question
altern
mechan
explain
action
nacetylcystein
nac
reduc
copd
exacerb
human
lung
model
nac
could
restor
antivir
cytokin
respons
prevent
inhibitori
effect
cigarett
smoke
extract
cse
viralmedi
retino
acidinduc
gene
rigi
import
pattern
recognit
receptor
sens
infl
uenza
dosedepend
effect
nac
innat
immun
respons
support
use
higherdos
nac
treatment
patient
chronic
copd
shown
previou
effect
high
dose
nacetylcystein
air
trap
airway
resist
chronic
obstruct
pulmonari
diseasea
doubleblind
random
placebocontrol
trial
hiac
reserv
conclud
effect
innat
immun
system
major
mechan
reduc
copd
exacerb
first
infl
uenza
infect
sole
caus
copd
exacerb
fact
respiratori
virus
human
rhinoviru
respiratori
syncyti
viru
human
metapneumoviru
coronaviru
adenovirus
recogn
exacerb
major
patient
copd
hiac
exsmok
unknown
whether
cigarett
smoke
sustain
longterm
suppress
effect
innat
immun
respons
moreov
present
still
limit
clinic
data
patient
copd
demonstr
interact
cigarett
smoke
nac
virusinduc
exacerb
extrapol
vivo
result
patient
copd
seem
clinic
studi
warrant
especi
demonstr
attenu
innat
immun
respons
patient
copd
clinic
effect
nac
enhanc
innat
respons
well
reduc
virusinduc
exacerb
patient
copd
fact
exacerb
copd
multifactori
nac
may
act
variou
target
site
result
reduct
exacerb
addit
mucolyt
effect
antioxid
antiinfl
ammatori
properti
nac
could
attenu
chronic
airway
infl
ammat
well
improv
small
airway
function
reduc
air
trap
exampl
patient
copd
character
overexpress
adhes
molecul
eg
intercellular
adhes
caus
excess
transmigr
neutrophil
shown
vitro
studi
nac
could
exert
antiinfl
ammatori
effect
inhibit
cytokin
stimul
intercellular
adhes
endotheli
epitheli
cell
effect
demonstr
nac
includ
reduct
lysozym
lactoferrin
concentr
smoker
reduct
activ
number
neutrophil
macrophag
bal
fl
uid
smoker
inhibit
adher
bacteria
ciliat
epitheli
cell
vitro
nevertheless
author
comment
defi
nite
shed
light
potenti
mechan
previou
observ
nac
could
reduc
exacerb
patient
copd
clinic
studi
warrant
confi
rm
hypothesi
editor
read
great
interest
recent
articl
holley
et
al
chest
septemb
detail
natur
vte
combat
soldier
previous
publish
fi
rst
report
knowledg
popul
agre
applic
vte
prophylaxi
injur
soldier
often
limit
bleed
risk
anatom
locat
injuri
discontinu
care
aris
surgic
logist
intervent
although
encourag
holley
et
al
note
reduct
vte
event
higher
dose
enoxaparin
contrast
data
somewhat
contradictori
miss
dose
appear
infl
uenc
vte
rate
opinion
two
develop
markedli
impact
care
patient
injur
recent
confl
ict
afghanistan
iraq
increas
incid
profund
penetr
injuri
impress
capabl
expedit
aeromed
evacu
emerg
latter
decreas
time
intheat
injuri
statesid
icu
injur
american
soldier
h
instanc
place
lengthi
transport
injur
fl
ight
time
h
within
time
period
vte
develop
prophylaxi
like
essenti
vagari
wartim
transport
may
compromis
administr
prophylaxi
moreov
condit
hypobar
hypoxia
seen
air
travel
may
increas
risk
vte
independ
risk
associ
prolong
immobl
increas
propens
patient
develop
clot
although
hypobar
risk
may
mitig
lowmolecularweight
heparin
aggress
thromboprophylaxi
trauma
set
certainli
justifi
abl
holley
et
al
note
absenc
data
evacu
period
remain
problemat
develop
tailor
evidencebas
approach
vte
prevent
popul
